JP2023530515A5 - - Google Patents
Info
- Publication number
- JP2023530515A5 JP2023530515A5 JP2022578936A JP2022578936A JP2023530515A5 JP 2023530515 A5 JP2023530515 A5 JP 2023530515A5 JP 2022578936 A JP2022578936 A JP 2022578936A JP 2022578936 A JP2022578936 A JP 2022578936A JP 2023530515 A5 JP2023530515 A5 JP 2023530515A5
- Authority
- JP
- Japan
- Prior art keywords
- ser
- polypeptide according
- pharmaceutically acceptable
- acceptable salt
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021026360 | 2020-06-22 | ||
| IN202021026360 | 2020-06-22 | ||
| IN202121002838 | 2021-01-20 | ||
| IN202121002838 | 2021-01-20 | ||
| PCT/IB2021/055457 WO2021260530A1 (en) | 2020-06-22 | 2021-06-21 | Long acting glp-1/gip dual agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530515A JP2023530515A (ja) | 2023-07-18 |
| JP2023530515A5 true JP2023530515A5 (https=) | 2024-06-26 |
| JP7849310B2 JP7849310B2 (ja) | 2026-04-21 |
Family
ID=76891103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578936A Active JP7849310B2 (ja) | 2020-06-22 | 2021-06-21 | 長時間作用性ｇｌｐ－１／ｇｉｐデュアルアゴニスト |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20230241178A1 (https=) |
| EP (1) | EP4146248A1 (https=) |
| JP (1) | JP7849310B2 (https=) |
| KR (1) | KR20230023658A (https=) |
| CN (1) | CN115768460A (https=) |
| AU (1) | AU2021296376A1 (https=) |
| BR (1) | BR112022025615A2 (https=) |
| CA (1) | CA3183358A1 (https=) |
| CL (1) | CL2022003654A1 (https=) |
| CO (1) | CO2022018464A2 (https=) |
| EC (1) | ECSP22095556A (https=) |
| IL (1) | IL299195A (https=) |
| JO (1) | JOP20220344A1 (https=) |
| MX (1) | MX2022016032A (https=) |
| PE (1) | PE20230861A1 (https=) |
| PH (1) | PH12022553526A1 (https=) |
| TW (1) | TW202216746A (https=) |
| WO (1) | WO2021260530A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20231309A1 (es) * | 2020-10-17 | 2023-08-24 | Sun Pharmaceutical Ind Ltd | Agonistas duales glp-1/gip |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| US12281149B2 (en) | 2021-05-13 | 2025-04-22 | Carmot Therapeutics, Inc. | Modulators of G-protein coupled receptors |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| WO2024098718A1 (zh) * | 2022-11-07 | 2024-05-16 | 内蒙古博睿精创科技有限公司 | 一种新型长效多肽化合物、组合物及其应用 |
| CN120865433A (zh) * | 2022-12-21 | 2025-10-31 | 勃林格殷格翰国际有限公司 | Glp1/gip/npy2受体的三重激动剂 |
| WO2024165571A2 (en) | 2023-02-06 | 2024-08-15 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| KR20260022948A (ko) | 2023-06-09 | 2026-02-20 | 썬 파마슈티컬 인더스트리스 리미티드 | Glp-1/gip 이중 수용체 작용제, glp-1/gcg 이중 수용체 작용제, 및 glp-1/gip/gcg 삼중 수용체 작용제 |
| WO2025125576A2 (en) | 2023-12-15 | 2025-06-19 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| WO2025133348A1 (en) | 2023-12-22 | 2025-06-26 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| EP4686757A1 (en) | 2024-07-31 | 2026-02-04 | e-therapeutics PLC | Inhibitors of expression and/or function |
| WO2025163615A1 (en) | 2024-01-31 | 2025-08-07 | Sun Pharmaceutical Industries Ltd. | High level production of glp1 analogues |
| WO2025196502A1 (en) | 2024-03-20 | 2025-09-25 | North Carolina Agricultural & Technical State University | Choline kinase inhibitors as a therapeutic treatment for obesity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120123443A (ko) * | 2010-01-27 | 2012-11-08 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트 |
| IN2014MN02304A (https=) * | 2012-05-03 | 2015-08-07 | Zealand Pharma As | |
| WO2015067715A2 (en) | 2013-11-06 | 2015-05-14 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
| TWI582109B (zh) * | 2015-01-09 | 2017-05-11 | 美國禮來大藥廠 | Ｇｉｐ及ｇｌｐ－１共促效劑化合物 |
| TWI622596B (zh) | 2015-10-26 | 2018-05-01 | 美國禮來大藥廠 | 升糖素受體促效劑 |
| MX2020010505A (es) * | 2018-04-05 | 2021-01-15 | Sun Pharmaceutical Ind Ltd | Analogos novedosos de glp-1. |
| CN119499352A (zh) | 2018-07-23 | 2025-02-25 | 伊莱利利公司 | 使用gip/glp1共激动剂用于糖尿病的方法 |
| KR20240051304A (ko) * | 2018-07-23 | 2024-04-19 | 일라이 릴리 앤드 캄파니 | Gip/glp1 공효능제 화합물 |
-
2021
- 2021-06-18 TW TW110122388A patent/TW202216746A/zh unknown
- 2021-06-21 IL IL299195A patent/IL299195A/en unknown
- 2021-06-21 MX MX2022016032A patent/MX2022016032A/es unknown
- 2021-06-21 EP EP21740614.9A patent/EP4146248A1/en active Pending
- 2021-06-21 CA CA3183358A patent/CA3183358A1/en active Pending
- 2021-06-21 PH PH1/2022/553526A patent/PH12022553526A1/en unknown
- 2021-06-21 BR BR112022025615A patent/BR112022025615A2/pt unknown
- 2021-06-21 WO PCT/IB2021/055457 patent/WO2021260530A1/en not_active Ceased
- 2021-06-21 US US18/002,478 patent/US20230241178A1/en active Pending
- 2021-06-21 CN CN202180042855.9A patent/CN115768460A/zh active Pending
- 2021-06-21 AU AU2021296376A patent/AU2021296376A1/en active Pending
- 2021-06-21 JP JP2022578936A patent/JP7849310B2/ja active Active
- 2021-06-21 KR KR1020227043963A patent/KR20230023658A/ko active Pending
- 2021-06-21 PE PE2022002928A patent/PE20230861A1/es unknown
-
2022
- 2022-12-19 EC ECSENADI202295556A patent/ECSP22095556A/es unknown
- 2022-12-19 CL CL2022003654A patent/CL2022003654A1/es unknown
- 2022-12-20 JO JOJO/P/2022/0344A patent/JOP20220344A1/ar unknown
- 2022-12-20 CO CONC2022/0018464A patent/CO2022018464A2/es unknown
-
2024
- 2024-08-22 US US18/812,726 patent/US20240424063A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530515A5 (https=) | ||
| JP2023545662A5 (https=) | ||
| JP7830441B2 (ja) | Ｇｌｐ－１／ｇｉｐ二重アゴニスト | |
| JP7849310B2 (ja) | 長時間作用性ｇｌｐ－１／ｇｉｐデュアルアゴニスト | |
| JP2810240B2 (ja) | サイトカイン調節剤およびサイトカインレベルの変化に関連する病状および状態における使用方法 | |
| CA2667280C (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| US6187751B1 (en) | Biologically active peptide of ob protein | |
| CN103314010B (zh) | h[Gly2]GLP-2的固相合成 | |
| CN102171244A (zh) | 糖依赖性胰岛素释放肽的类似物 | |
| RU2007110981A (ru) | Урокортин iii и его использование | |
| PL176208B1 (pl) | Nowa klasa peptydów o wysokiej czynności biologicznej i środek farmaceutyczny je zawierający | |
| JP2024543204A5 (https=) | ||
| CA2139947C (en) | Calcium channel blocking polypeptide from agelenopsis aperta | |
| KR20180052642A (ko) | 장시간 작용형 아드레노메둘린 유도체 | |
| US6489297B1 (en) | Vasoactive intestinal peptide analogs | |
| JP2021523945A5 (https=) | ||
| US6075009A (en) | Neuropeptide Y analogues, compositions and methods of lowering blood pressure | |
| JP7854211B2 (ja) | ヘマグルチニン結合ペプチド | |
| WO2024153090A1 (zh) | 基于glp-1的三重激动剂 | |
| JPH08502250A (ja) | 成長ホルモン放出ペプチド | |
| JP2021523946A5 (https=) | ||
| JP2024527220A5 (https=) | ||
| JPH03501858A (ja) | Ｃｒｆ類似体 | |
| WO1993023428A1 (en) | Calcium channel blocking polypeptides from filistata hibernalis | |
| US5627154A (en) | Calcium channel blocking polypeptides from Heteropoda venatoria |